HCPCS Level II
J9206
Injection, irinotecan, 20 mg
Codes near J9206
These sit next to J9206 in the CMS Level II file. All J codes
- J9201Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
- J9202Goserelin acetate implant, per 3.6 mg
- J9203Injection, gemtuzumab ozogamicin, 0.1 mg
- J9204Injection, mogamulizumab-kpkc, 1 mg
- J9205Injection, irinotecan liposome, 1 mg
- J9207Injection, ixabepilone, 1 mg
- J9208Injection, ifosfamide, 1 gram
- J9209Injection, mesna, 200 mg
- J9210Injection, emapalumab-lzsg, 1 mg
- J9211Injection, idarubicin hydrochloride, 5 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00009-0082-02 | Camptosar | Pfizer Inc | 15 |
| 00009-0112-05 | Camptosar | Pfizer Inc | 5 |
| 00009-7529-03 | Camptosar | Pfizer Inc | 5 |
| 00009-7529-04 | Camptosar | Pfizer Inc | 2 |
| 00009-7529-05 | Camptosar | Pfizer Inc | 15 |
| 00009-7529-10 | Camptosar | Pfizer Inc | 2 |
| 00143-9701-01 | Irinotecan HCl | Hikma Pharmaceuticals USA Inc. | 5 |
| 00143-9702-01 | Irinotecan HCl | Hikma Pharmaceuticals USA Inc. | 2 |
| 16714-0027-01 | Irinotecan HCl | Northstar RxLLC | 2 |
| 16714-0131-01 | Irinotecan HCl | Northstar RxLLC | 5 |
| 25021-0230-02 | Irinotecan HCl | Sagent Pharmaceuticals | 2 |
| 25021-0230-05 | Irinotecan HCl | Sagent Pharmaceuticals | 5 |
| 45963-0614-51 | Irinotecan HCl | Actavis Pharma, Inc. | 2 |
| 45963-0614-55 | Irinotecan HCl | Actavis Pharma, Inc. | 5 |
| 50742-0401-02 | Irinotecan HCl | Ingenus Pharmaceuticals LLC | 2 |
| 50742-0402-05 | Irinotecan HCl | Ingenus Pharmaceuticals LLC | 5 |
| 55150-0352-01 | Irinotecan HCl | Eugia US LLC | 2 |
| 55150-0353-01 | Irinotecan HCl | Eugia US LLC | 5 |
| 55150-0354-01 | Irinotecan HCl | Eugia US LLC | 15 |
| 60505-6128-00 | Irinotecan HCl | Apotex Corp | 2 |
| 60505-6128-01 | Irinotecan HCl | Apotex Corp | 5 |
| 60505-6272-01 | Irinotecan HCl | Apotex Corp | 5 |
| 61703-0349-09 | Irinotecan HCl | Pfizer Inc | 5 |
| 61703-0349-16 | Irinotecan HCl | Pfizer Inc | 2 |
| 61703-0349-36 | Irinotecan HCl | Pfizer Inc | 25 |
| 63323-0193-52 | Irinotecan HCl | FreseniUS Kabi USA, LLC | 2 |
| 63323-0193-55 | Irinotecan HCl | FreseniUS Kabi USA, LLC | 5 |
| 68001-0480-22 | Irinotecan HCl | BluePoint Laboratories | 5 |
| 68001-0480-35 | Irinotecan HCl | BluePoint Laboratories | 2 |
| 70700-0169-22 | Irinotecan HCl | Xiromed, LLC | 2 |
| 70700-0170-22 | Irinotecan HCl | Xiromed, LLC | 5 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.